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Propionibacterium acnes  
and Sebaceous Lipogenesis:  
A Love–Hate Relationship?
Christos C. Zouboulis1,2
In this issue, Iinuma et al. show that Propionibacterium acnes (P. acnes)–
 conditioned medium and formalin-killed P. acnes augment intracellular 
lipid formation in hamster sebocytes by increasing the de novo synthesis of 
triacylglycerols. This commentary summarizes the current knowledge of the 
association of P. acnes with sebaceous lipogenesis, inflammation, and innate 
immunity, and points out the concurrent evidence that P. acnes–induced lipids 
may represent a recruitment of allies and/or enemies of the human skin.
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Dermatologists’ understanding of the 
association of the gram-positive, anaero-
bic Propionibacterium acnes (P. acnes, 
formerly Corynobacterium acnes) with 
acne vulgaris has changed substantially 
over the past decade (Zouboulis et al., 
2005). P. acnes has successively been 
considered (i) a bacterium responsible for 
the development of acne lesions (Brown 
and Shalita, 1998), (ii) a microbial spe-
cies with a role in aggravating acne but 
not in its initiation (Zouboulis, 2001), and 
(iii) a commensal bacterium whose pres-
ence may be skin protective and essential 
for innate immunity (Koreck et al., 2003; 
Georgel et al., 2005). Recent discoveries 
have transformed the concept of acne 
vulgaris from that of a simple temporary 
clinical problem to a model disease for 
investigating innate immunity.
The significance of the involve-
ment of P. acnes in acne pathogenesis 
remains controversial, mainly owing to 
its presence in the resident microbiota 
of healthy skin (Leyden et al. 1998). The 
recent decoding of the P. acnes genome 
revived the possibility of a pathogenic 
role (Brüggemann et al., 2004). This was 
further supported by the fact that P. acnes 
induces IL-12 and IL-8 protein production 
by primary human monocytes via a Toll-
like receptor 2 (TLR2)-regulated pathway 
and that TLR2 is expressed on the cell 
surface of macrophages surrounding 
pilosebaceous follicles of acne lesions 
(Kim et al., 2002). Moreover, functional 
TLR2 is also expressed in human kerati-
nocytes and SZ95 sebocytes (Pivarcsi et 
al., 2003; Oeff et al., 2006). TLR2 and 
TLR4 expression was increased in the 
epidermis of acne lesions, and P. acnes 
was found to induce TLR expression in 
human keratinocytes in vitro (Jugeau et 
al., 2005). On the other hand, P. acnes 
extracts have recently been implicated 
in the formation of microcomedones 
(Jarrousse et al., 2007).
P. acnes and sebaceous lipids
In this issue, Iinuma et al. (2009) show 
that P. acnes-conditioned medium and 
formalin-killed P. acnes derived from 
several P. acnes strains augment intra-
cellular formation of lipid droplets in 
hamster sebocytes by increasing the 
de novo synthesis of triacylglycerols 
in vivo and in vitro. P. acnes appears to 
participate directly in the augmentation 
of sebaceous lipo genesis through an 
increase in 15-deoxy-Δ12,14-prostaglandin 
J2 (15d-PGJ2) production, leading to 
enhanced production of diacylglycerol 
acyltransferase 1–dependent triacylgly-
c erol (Iwata et al., 2005). These results 
indicate a direct role for P. acnes in the 
enhancement of sebaceous lipogenesis 
through P. acnes-derived soluble factor(s). 
The question of whether P. acnes and/
or P. acnes-derived factors are largely 
responsible for the development of seba-
ceous lipids is considered below.
P. acnes, sebaceous lipogenesis,  
and inflammation
When applied directly to human sebo-
cyte cultures in vitro, fatty acids such 
as arachidonic acid (AA), a long-chain, 
proinflammatory ω-6 fatty acid and pre-
cursor of leukotriene B4 (LTB4; Alestas et 
al., 2006), and linoleic acid, an essential 
dietary fatty acid (Wróbel et al., 2003), 
stimulate IL-6 and IL-8 synthesis and 
enhance the synthesis of sebaceous lip-
ids. 5-Lipoxygenase (5-LOX) metabolizes 
AA to LTB4, which induces recruitment 
and activation of neutrophils, monocytes, 
and eosinophils. It also stimulates the 
production of several proinflammatory 
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hormone (CRH) augments the synthesis 
of sebaceous lipids in vitro (Zouboulis 
et al., 2002) and induces IL-6 and IL-8 
release by human sebocytes, mediated 
by the CRH receptor 1 (Krause et al., 
2007). The CRH product adrenocortico-
tropic hormone causes the production 
of adrenal dehydroepiandrosterone to 
further induce skin inflammation (Alesci 
and Bornstein, 2000). CRH is expressed 
in human sebocytes in vivo and in vitro 
and is upregulated in acne-involved 
sebaceous glands (Ganceviciene et al., 
2009). These findings indicate that stress 
(Slominski et al., 1999) may influence 
the development of clinical inflamma-
tion in early acne lesions.
Moreover, adrenocorticotropic hor-
mone and the potent melanocyte-
 stimulating hormone (MSH) analog 
[Nle4, D-Phe7]-α-MSH increase squalene 
synthesis in primary human sebocytes 
(Zhang et al., 2003). In line with the 
immunoregulatory actions of α-MSH, 
this peptide was also found to suppress 
basal and IL-1β–induced secretion of IL-8 
in SZ95 sebocytes (Böhm et al., 2002). 
Human sebocytes concomitantly express 
melanocortin (MC)-1 receptor and MC-5 
receptor (Böhm et al., 2002; Thiboutot 
et al., 2001), but the MC-1 receptor is 
involved in pilosebaceous immunoregu-
lation and inflammation (Ganceviciene 
et al., 2007), whereas the MC-5 receptor 
is involved in sebocyte differentiation and 
lipogenesis (Zhang et al., 2006a).
P. acnes, sebaceous lipogenesis,  
and innate immunity
The recent identification of phylogeneti-
cally distinct P. acnes clusters (McDowell 
et al., 2005, 2008) challenges our under-
standing of the pathogenic nature of 
bacteria in acne pathogenesis and rais-
es the possibility that certain P. acnes 
strains may cause opportunistic infec-
tion, exacerbating acne lesions. This lat-
ter possibility becomes more likely after 
a bacteria-protective biofilm is formed 
(Coenye et al., 2008; Holmberg et al., 
2009). Indeed, phylogenetic clusters 
of P. acnes differ not only in their pro-
duction of secreted proteins but also in 
their ability to induce different immune 
responses in the immunocompetent 
pilosebaceous unit. The major difference 
is the ability of P. acnes and its products 
to induce human β-defensin-2 (hBD2) 
Stearoyl coenzyme A desaturase, an 
enzyme responsible for the biosynthesis of 
monounsaturated fatty acids, is expressed 
by human sebocytes in vivo and in vitro 
(Georgel et al., 2005; Harrison et al., 
2007). Monounsaturated fatty acids—
mainly palmitic acid (C16:1) and oleic 
acid (C18:1), both of which are bacteri-
cidal against gram-positive organisms 
(Georgel et al., 2005)—are produced by 
sebaceous glands, as is sapienic acid, 
another important anti microbial lipid. 
Palmitic acid, oleic acid, and lauric acid 
have been proposed as active agents in 
an alternative natural antibiotic therapy 
for acne vulgaris (Georgel et al., 2005; 
Nakatsuji et al., 2009). Interestingly, 
the TLR2 ligand, bacteria-derived 
macrophage-activating lipopeptide-2, 
stimulates both stearoyl coenzyme A 
desaturase and fatty acid desaturase-2 
mRNA expression in SZ95 sebocytes 
(Georgel et al., 2005). Furthermore, free 
fatty acids in sebum are not likely to be 
solely bacterial products because cul-
tured human sebocytes are able to pro-
duce free fatty acids in the absence of 
bacteria (Zouboulis et al., 1999).
Expression of liver X receptors (LXRs) 
α and β has been detected in SZ95 sebo-
cytes (Russell et al., 2007), and LXR lig-
ands enhance the expression of LXRα, 
inhibit cell proliferation, and stimulate 
lipid synthesis (Russell et al., 2007; Hong 
et al., 2008). LXRs are members of the 
nuclear receptor superfamily, which 
plays a critical role in cholesterol home-
ostasis and lipid metabolism. They also 
decrease the expression of COX-2 and 
inducible nitric oxide synthase upregu-
lated by treatment with polysaccharides, 
a function that indicates an important 
role for LXRα in the differentiation and 
inflammatory signaling in sebaceous 
glands (Hong et al., 2008).
Neuropeptides are pilosebaceous 
stressors that enhance sebaceous 
lipogenesis. Corticotropin- releasing 
cytokines and mediators that augment 
and prolong tissue inflammation. 5-LOX 
production is enhanced in the sebaceous 
glands of acne patients (Alestas et al., 
2006), and its in vivo inhibition reduces 
the production of proinflammatory seba-
ceous fatty acids as well as the number of 
inflammatory acne lesions (Zouboulis et 
al., 2003). In addition, human sebocytes 
express functional platelet-activating fac-
tor receptors, which are involved in reg-
ulating the expression of inflammatory 
mediators, including cyclooxygenase-2 
(COX-2), prostaglandin E2 (PGE2), and 
IL-8 (Zhang et al., 2006c). COX-2 levels 
are enhanced in acne-involved seba-
ceous glands, where it augments seba-
ceous lipogenesis (Neufang et al., 2001) 
and contributes to the high PGE2 levels 
detected in AA-challenged human sebo-
cytes in vitro (Alestas et al., 2006).
Interestingly, LTB4 binds and acti-
vates peroxisome proliferator–activated 
receptor-α (PPARα), which can modu-
late inflammatory responses in several 
cell types by inhibiting the expression of 
proinflammatory genes that regulate the 
production of cytokines, metalloprotein-
ases, and acute-phase proteins (Delerive 
et al., 2001). In addition, squalene per-
oxides—proinflammatory products of 
sebaceous lipid oxidation detected in 
acne—induce an initial upregulation of 
IL-6 production and secretion in cultured 
human keratinocytes that is counteracted 
by PPARα (Ottaviani et al., 2006). On the 
other hand, COX-2 expression and PGE2 
production are enhanced by PPARγ ago-
nists (Zhang et al., 2006b). Moreover, 
15d-PGJ2 has been reported to be an 
endogenous activator of PPARγ (Kliewer 
et al., 1995; Ma et al., 1998), and PPARγ 
agonists have been shown to augment 
lipogenesis (Trivedi et al., 2006). PPARs 
are expressed in rat and human sebo-
cytes in vivo and in vitro (Rosenfield et 
al., 1999; Chen et al., 2003; Alestas et 
al., 2006; Trivedi et al., 2006). They are 
regulated by fatty acid derivatives, con-
trol lipid and lipoprotein metabolism, 
and negatively regulate the transcription 
of inflammatory response genes. This is 
accomplished by antagonizing the AP-1, 
NF-κB, signal transducer and activator of 
transcription, and nuclear factor of acti-
vated T-cell signaling pathways and by 
stimulating the catabolism of proinflam-
matory eicosanoids (Weindl et al., 2005).
|The roles of  P. acnes in sebaceous gland function 
remain uncertain.
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may facilitate antimicrobial peptide 
induction without inflammation. It was 
recently proposed that the beneficial 
effects of resident microbiota may be 
due to their ability to induce antimi-
crobial peptide expression, thereby 
supporting effective innate immu-
nity (Georgel et al., 2005; Schröder 
and Harder, 2006). The identification 
of P. acnes proteins that induce anti-
microbial peptides without inducing 
proinflammatory cytokine/chemok-
ine expression would promote healthy 
levels of antimicrobial peptides and, 
consequently, resistance to abnormal 
P. acnes colonization.
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An “Ice-Cold” TR(i)P to Skin Biology: 
The Role of TRPA1 in Human 
Epidermal Keratinocytes
Tamás Bíró1 and László Kovács1
Recent studies have suggested the expression of numerous heat-sensitive 
transient receptor potential (TRP) ion channels in non-neuronal cell popula-
tions of the skin. In this issue, Atoyan et al. provide evidence that the noxious 
cold-activated TRPA1 is widely expressed in various human cutaneous cells and 
that it may be directly involved in the regulation of keratinocyte proliferation 
and differentiation and in cutaneous inflammatory responses.
Journal of Investigative Dermatology (2009) 129, 2096–2099. doi:10.1038/jid.2009.179
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thermosensitive transient receptor 
potential ion channels
Alteration in external temperature is a 
common challenge to homoeothermic 
organisms, initiating a coordinated 
response to maintain constant core 
temperature. Importantly, the sensory 
afferent as well as the majority of 
executive efferent mechanisms of the 
thermoregulatory response take place 
chiefly in the skin.
The key target molecules of tem-
perature challenge are members of the 
large transient receptor potential (TRP) 
